Analytical BioSciences

Analytical BioSciences is a private biotechnology company focused on drug target and therapeutic discovery using single-cell genomics, spatial omics, and bioinformatics. The company builds large-scale disease cell atlases and applies proprietary analytics to identify biomarkers, validate targets, and generate therapeutic hypotheses for biotech and pharmaceutical partners. In addition to discovery services, it out-licenses validated targets and therapeutic antibody assets for downstream drug development. Its commercial offerings include end-to-end single-cell and spatial omics services as well as its OmniBrowser and OmniDatasets platforms built on a large internal single-cell database. The company appears to be oriented primarily toward preclinical discovery, especially in innate immunity, tumor microenvironment biology, and broader precision medicine applications.